| UniProt ID | RSRC2_HUMAN | |
|---|---|---|
| UniProt AC | Q7L4I2 | |
| Protein Name | Arginine/serine-rich coiled-coil protein 2 | |
| Gene Name | RSRC2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 434 | |
| Subcellular Localization | ||
| Protein Description | ||
| Protein Sequence | MAASDTERDGLAPEKTSPDRDKKKEQSEVSVSPRASKHHYSRSRSRSRERKRKSDNEGRKHRSRSRSKEGRRHESKDKSSKKHKSEEHNDKEHSSDKGRERLNSSENGEDRHKRKERKSSRGRSHSRSRSRERRHRSRSRERKKSRSRSRERKKSRSRSRERKKSRSRSRERKRRIRSRSRSRSRHRHRTRSRSRTRSRSRDRKKRIEKPRRFSRSLSRTPSPPPFRGRNTAMDAQEALARRLERAKKLQEQREKEMVEKQKQQEIAAAAATGGSVLNVAALLASGTQVTPQIAMAAQMAALQAKALAETGIAVPSYYNPAAVNPMKFAEQEKKRKMLWQGKKEGDKSQSAEIWEKLNFGNKDQNVKFRKLMGIKSEDEAGCSSVDEESYKTLKQQEEVFRNLDAQYEMARSQTHTQRGMGLGFTSSMRGMDAV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAASDTERD ------CCCCCCCCC | 18.70 | 21406692 | |
| 4 | Phosphorylation | ----MAASDTERDGL ----CCCCCCCCCCC | 35.21 | 29255136 | |
| 6 | Phosphorylation | --MAASDTERDGLAP --CCCCCCCCCCCCC | 30.35 | 29255136 | |
| 16 | Phosphorylation | DGLAPEKTSPDRDKK CCCCCCCCCCCCHHH | 43.78 | 29255136 | |
| 17 | Phosphorylation | GLAPEKTSPDRDKKK CCCCCCCCCCCHHHH | 35.55 | 29255136 | |
| 27 | Phosphorylation | RDKKKEQSEVSVSPR CHHHHHHCCCCCCHH | 40.85 | 29255136 | |
| 30 | Phosphorylation | KKEQSEVSVSPRASK HHHHCCCCCCHHHHH | 16.90 | 29255136 | |
| 32 | Phosphorylation | EQSEVSVSPRASKHH HHCCCCCCHHHHHHH | 10.93 | 19664994 | |
| 36 | Phosphorylation | VSVSPRASKHHYSRS CCCCHHHHHHHHCHH | 33.53 | 30576142 | |
| 40 | Phosphorylation | PRASKHHYSRSRSRS HHHHHHHHCHHHHHH | 12.90 | 29083192 | |
| 41 | Phosphorylation | RASKHHYSRSRSRSR HHHHHHHCHHHHHHH | 21.30 | 29083192 | |
| 43 | Phosphorylation | SKHHYSRSRSRSRER HHHHHCHHHHHHHHH | 28.77 | 29083192 | |
| 45 | Phosphorylation | HHYSRSRSRSRERKR HHHCHHHHHHHHHHH | 35.54 | 20068231 | |
| 47 | Phosphorylation | YSRSRSRSRERKRKS HCHHHHHHHHHHHHC | 39.48 | 20068231 | |
| 63 | Phosphorylation | NEGRKHRSRSRSKEG CCHHHHHHHHHCHHH | 34.04 | 17081983 | |
| 65 | Phosphorylation | GRKHRSRSRSKEGRR HHHHHHHHHCHHHHC | 42.00 | 17081983 | |
| 67 | Phosphorylation | KHRSRSRSKEGRRHE HHHHHHHCHHHHCCC | 35.98 | 26657352 | |
| 94 | Phosphorylation | EHNDKEHSSDKGRER HCCCCCCCCHHHHHH | 41.13 | 30576142 | |
| 95 | Phosphorylation | HNDKEHSSDKGRERL CCCCCCCCHHHHHHH | 45.29 | 23312004 | |
| 104 | Phosphorylation | KGRERLNSSENGEDR HHHHHHHCCCCCHHH | 43.55 | 29255136 | |
| 105 | Phosphorylation | GRERLNSSENGEDRH HHHHHHCCCCCHHHH | 33.73 | 30266825 | |
| 126 | Phosphorylation | SSRGRSHSRSRSRER HHHCCCHHHHHHHHH | 32.95 | 17081983 | |
| 128 | Phosphorylation | RGRSHSRSRSRERRH HCCCHHHHHHHHHHH | 37.31 | 20068231 | |
| 130 | Phosphorylation | RSHSRSRSRERRHRS CCHHHHHHHHHHHHH | 39.48 | 20068231 | |
| 137 | Phosphorylation | SRERRHRSRSRERKK HHHHHHHHHHHHHHH | 28.60 | 17081983 | |
| 139 | Phosphorylation | ERRHRSRSRERKKSR HHHHHHHHHHHHHHH | 39.48 | 17081983 | |
| 145 | Phosphorylation | RSRERKKSRSRSRER HHHHHHHHHHHHHHH | 38.22 | 26074081 | |
| 147 | Phosphorylation | RERKKSRSRSRERKK HHHHHHHHHHHHHHH | 41.52 | 20068231 | |
| 149 | Phosphorylation | RKKSRSRSRERKKSR HHHHHHHHHHHHHHH | 39.48 | 20068231 | |
| 155 | Phosphorylation | RSRERKKSRSRSRER HHHHHHHHHHHHHHH | 38.22 | - | |
| 157 | Phosphorylation | RERKKSRSRSRERKK HHHHHHHHHHHHHHH | 41.52 | 20068231 | |
| 159 | Phosphorylation | RKKSRSRSRERKKSR HHHHHHHHHHHHHHH | 39.48 | 20068231 | |
| 165 | Phosphorylation | RSRERKKSRSRSRER HHHHHHHHHHHHHHH | 38.22 | 26074081 | |
| 167 | Phosphorylation | RERKKSRSRSRERKR HHHHHHHHHHHHHHH | 41.52 | 20068231 | |
| 169 | Phosphorylation | RKKSRSRSRERKRRI HHHHHHHHHHHHHHH | 39.48 | 20068231 | |
| 198 | Phosphorylation | RSRSRTRSRSRDRKK HHHHHHHCHHHHHHH | 33.71 | 20068231 | |
| 200 | Phosphorylation | RSRTRSRSRDRKKRI HHHHHCHHHHHHHHH | 39.52 | 20068231 | |
| 214 | Phosphorylation | IEKPRRFSRSLSRTP HCHHHHHHHHHCCCC | 21.10 | 29116813 | |
| 216 | Phosphorylation | KPRRFSRSLSRTPSP HHHHHHHHHCCCCCC | 29.51 | 23927012 | |
| 218 | Phosphorylation | RRFSRSLSRTPSPPP HHHHHHHCCCCCCCC | 35.04 | 23927012 | |
| 220 | Phosphorylation | FSRSLSRTPSPPPFR HHHHHCCCCCCCCCC | 25.41 | 22167270 | |
| 222 | Phosphorylation | RSLSRTPSPPPFRGR HHHCCCCCCCCCCCC | 49.80 | 22167270 | |
| 231 | Phosphorylation | PPFRGRNTAMDAQEA CCCCCCCCCHHHHHH | 23.23 | 28555341 | |
| 233 | Sulfoxidation | FRGRNTAMDAQEALA CCCCCCCHHHHHHHH | 4.06 | 21406390 | |
| 317 | Phosphorylation | TGIAVPSYYNPAAVN HCCCCCCCCCHHHCC | 10.95 | 22817900 | |
| 327 | Ubiquitination | PAAVNPMKFAEQEKK HHHCCHHHHHHHHHH | 42.55 | - | |
| 333 | 2-Hydroxyisobutyrylation | MKFAEQEKKRKMLWQ HHHHHHHHHHHHHHC | 58.53 | - | |
| 342 | Acetylation | RKMLWQGKKEGDKSQ HHHHHCCCCCCCHHH | 32.33 | 25953088 | |
| 348 | Phosphorylation | GKKEGDKSQSAEIWE CCCCCCHHHHHHHHH | 33.82 | 25627689 | |
| 350 | Phosphorylation | KEGDKSQSAEIWEKL CCCCHHHHHHHHHHH | 34.65 | 25159151 | |
| 356 | Ubiquitination | QSAEIWEKLNFGNKD HHHHHHHHHCCCCCC | 33.46 | - | |
| 362 | Ubiquitination | EKLNFGNKDQNVKFR HHHCCCCCCCCCHHH | 62.16 | - | |
| 375 | Sumoylation | FRKLMGIKSEDEAGC HHHHHCCCCCCCCCC | 41.90 | - | |
| 375 | Sumoylation | FRKLMGIKSEDEAGC HHHHHCCCCCCCCCC | 41.90 | 25114211 | |
| 376 | Phosphorylation | RKLMGIKSEDEAGCS HHHHCCCCCCCCCCC | 48.65 | 23401153 | |
| 383 | Phosphorylation | SEDEAGCSSVDEESY CCCCCCCCCCCHHHH | 32.26 | 25262027 | |
| 384 | Phosphorylation | EDEAGCSSVDEESYK CCCCCCCCCCHHHHH | 37.35 | 25159151 | |
| 389 | Phosphorylation | CSSVDEESYKTLKQQ CCCCCHHHHHHHHHH | 29.86 | 30108239 | |
| 390 | Phosphorylation | SSVDEESYKTLKQQE CCCCHHHHHHHHHHH | 15.98 | - | |
| 391 | Ubiquitination | SVDEESYKTLKQQEE CCCHHHHHHHHHHHH | 57.57 | - | |
| 394 | Ubiquitination | EESYKTLKQQEEVFR HHHHHHHHHHHHHHH | 55.99 | - | |
| 394 | Sumoylation | EESYKTLKQQEEVFR HHHHHHHHHHHHHHH | 55.99 | - | |
| 394 | Sumoylation | EESYKTLKQQEEVFR HHHHHHHHHHHHHHH | 55.99 | - | |
| 407 | Phosphorylation | FRNLDAQYEMARSQT HHHHHHHHHHHHHCC | 14.91 | 21945579 | |
| 409 | Sulfoxidation | NLDAQYEMARSQTHT HHHHHHHHHHHCCCC | 2.98 | 21406390 | |
| 418 | Methylation | RSQTHTQRGMGLGFT HHCCCCCCCCCCCCC | 37.92 | 54558911 | |
| 425 | Phosphorylation | RGMGLGFTSSMRGMD CCCCCCCCHHHCCCC | 20.35 | 26074081 | |
| 426 | Phosphorylation | GMGLGFTSSMRGMDA CCCCCCCHHHCCCCC | 21.63 | 26074081 | |
| 427 | Phosphorylation | MGLGFTSSMRGMDAV CCCCCCHHHCCCCCC | 14.94 | 26074081 | |
| 429 | Methylation | LGFTSSMRGMDAV-- CCCCHHHCCCCCC-- | 38.95 | 115492959 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RSRC2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RSRC2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RSRC2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| A4_HUMAN | APP | physical | 21832049 | |
| CKLF5_HUMAN | CMTM5 | physical | 25416956 | |
| KASH5_HUMAN | CCDC155 | physical | 25416956 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-6; THR-16; SER-17; SER-30 AND SER-32, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT THR-6; THR-16; SER-17; SER-30 AND SER-32, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30 AND SER-32, AND MASSSPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4; SER-17; SER-32;SER-104; SER-126; SER-216; SER-218; THR-220 AND SER-222, AND MASSSPECTROMETRY. | |